Stay updated on VX15/Avelumab Combo in NSCLC Clinical Trial

Sign up to get notified when there's something new on the VX15/Avelumab Combo in NSCLC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the VX15/Avelumab Combo in NSCLC Clinical Trial page

  1. Check
    6 days ago
    Change Detected
    Summary
    The page now indicates that no participants are being recruited. New help and navigation entries were added (How to Read a Study Record, Common Questions, How to Join a Study), and the Intervention/Treatment heading formatting was updated along with a revision note from v3.5.5 to v3.6.0.
    Difference
    0.4%
    Check dated 2026-06-16T00:15:37.000Z thumbnail image
  2. Check
    13 days ago
    Change Detected
    Summary
    Revision updated from v3.5.4 to v3.5.5, indicating a minor update to the page's documentation/versioning rather than substantive content changes.
    Difference
    0.1%
    Check dated 2026-06-09T01:25:44.000Z thumbnail image
  3. Check
    20 days ago
    No Change Detected
  4. Check
    27 days ago
    No Change Detected
  5. Check
    34 days ago
    Change Detected
    Summary
    The study record now shows revision v3.5.4, replacing the previous v3.5.3. This signals a minor update to the page content rather than a change to the study details.
    Difference
    0.1%
    Check dated 2026-05-18T13:41:25.000Z thumbnail image
  6. Check
    55 days ago
    Change Detected
    Summary
    The page’s footer revision label was updated from v3.5.2 to v3.5.3, reflecting a maintenance/version bump without altering the displayed study details.
    Difference
    0.1%
    Check dated 2026-04-27T08:10:37.000Z thumbnail image
  7. Check
    62 days ago
    Change Detected
    Summary
    Revision updated from v3.5.0 to v3.5.2.
    Difference
    0.1%
    Check dated 2026-04-20T05:16:44.000Z thumbnail image
  8. Check
    77 days ago
    Change Detected
    Summary
    Added a citation to iRECIST guidelines (Lancet Oncology 2017) in Publications and removed the Lancet Oncology 2019 erratum note from the same reference.
    Difference
    0.1%
    Check dated 2026-04-05T19:30:31.000Z thumbnail image

Stay in the know with updates to VX15/Avelumab Combo in NSCLC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the VX15/Avelumab Combo in NSCLC Clinical Trial page.